Durvalumab (Patient)
Medication Basics
Drug Name
Durvalumab (Brand names: Imfinzi®)
Purpose / Indication
Used to treat certain cancers, including lung cancer, biliary tract cancer, hepatocellular carcinoma, and other approved oncology indications as directed by the care team.
Dosage & Administration
Dose Schedule
Administered as an intravenous infusion on a schedule determined by cancer type, combination regimen, weight, and protocol; common schedules include every 2, 3, or 4 weeks.
Route
IV (Intravenous)
Timing Considerations
Treatment is given in cycles. The infusion schedule is determined by the oncology team and may change if side effects occur.
Time of Day
Flexible
Special Instructions
Keep all appointments and tell your care team about new symptoms before each treatment.
Injection Techniques
This medicine is given by trained healthcare professionals through an IV line.
Mechanism of Action
Mechanism
This medicine helps your immune system find and fight cancer cells by blocking a pathway that cancer cells may use to avoid immune detection.